| Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma |
Globe Newswire |
05/21 |
17:51 |
| Mountain America Credit Union Ranked Among USA Today’s Top 10 Workplaces for Third Consecutive Year |
Globe Newswire |
05/21 |
17:49 |
| Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026 |
Globe Newswire |
05/21 |
17:39 |
| YORK SPACE SYSTEMS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating York Space Systems Inc. on Behalf of York Space Systems Stockholders and Encourages Investors to Contact the Firm |
Globe Newswire |
05/21 |
17:36 |
| Free speech or race-baiting? Tennessee shooting stirs debate over livestreamer's approach |
AP Online |
05/21 |
17:32 |
| Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting |
Globe Newswire |
05/21 |
17:30 |
| Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting |
Globe Newswire |
05/21 |
17:29 |
| Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors |
Globe Newswire |
05/21 |
17:21 |
| Alexander Rossi is expected to start the Indianapolis 500 after medical team clears him to drive |
AP Online |
05/21 |
17:20 |
| CEO of NIL enforcement reminds frustrated schools: These are your rules, we just enforce them |
AP Online |
05/21 |
17:18 |
| The Latest: Trump says ‘it looks like I’ll be the one’ to intervene in Cuba after Castro indictment |
AP Online |
05/21 |
17:18 |
| Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering |
Globe Newswire |
05/21 |
17:15 |
| Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations |
Globe Newswire |
05/21 |
17:13 |
| Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 |
Globe Newswire |
05/21 |
17:10 |
| The Trump administration expands its use of AI in the hunt for healthcare fraud |
AP Online |
05/21 |
17:09 |
| US stocks edge higher following the latest U-turn for oil prices |
AP Online |
05/21 |
17:08 |
| Equus Announces First Quarter Net Asset Value |
Globe Newswire |
05/21 |
17:07 |
| ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES |
Globe Newswire |
05/21 |
17:06 |
| Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season |
Globe Newswire |
05/21 |
17:06 |
| Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026 |
Globe Newswire |
05/21 |
17:05 |
| Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology |
Globe Newswire |
05/21 |
17:05 |
| Imperial Announces Voting Results for the Election of Directors |
Globe Newswire |
05/21 |
17:02 |
| Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin |
Globe Newswire |
05/21 |
17:02 |
| Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis |
Globe Newswire |
05/21 |
17:01 |
| Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data |
Globe Newswire |
05/21 |
17:01 |
